Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 5;15(15):3469.
doi: 10.3390/nu15153469.

Benefits of the Light Consumption of Red Wine in Pain, Tender Points, and Anxiety in Women with Fibromyalgia: A Pilot Study

María Victoria González-López-Arza  1 , José Vicente Triviño-Palomo  1 , Jesús Montanero-Fernández  2 , Elisa María Garrido-Ardila  1 , Blanca González-Sánchez  1 , María Jiménez-Palomares  1 , Juan Rodríguez-Mansilla  1
Affiliations

Benefits of the Light Consumption of Red Wine in Pain, Tender Points, and Anxiety in Women with Fibromyalgia: A Pilot Study

María Victoria González-López-Arza et al. Nutrients. .

Abstract

Background: Fibromyalgia (FM) is characterized by chronic widespread pain, as well as anxiety, sadness, and depression. These symptoms are present in most patients and have a negative impact on their daily, family, and social life. The role of neurotransmitters in the pathophysiology of FM has been extensively discussed. The scientific evidence shows that levels of serotonin are decreased in patients with FM. Numerous studies support the beneficial effects that moderate wine consumption has on the body, with cardiovascular, endocrine, bone, and muscle improvements.

Objective: The objective of this pilot study was to assess whether light consumption of red wine improves the main symptoms of FM.

Methods: The study consisted of an experimental study with a control group with a total of 60 women diagnosed with FM following the American College of Rheumatology's criteria. The experimental group ingested 15 g of alcohol per day, in the form of red wine, over a period of four weeks. The outcome measures were: the level of pain in tender points, sadness, anxiety, depression, and quality of life. The assessments tools were: tender point graphics, the visual analogue scale (for the assessment of pain and sadness), the Hamilton Anxiety Scale, the Hamilton Depression Rating Scale, and the Fibromyalgia Impact Questionnaire. The measurements were completed before and after the consumption of red wine. In addition, the differences between groups were evaluated in terms of drug consumption in the pre-intervention and follow-up phases.

Results: Statistically significant improvements were obtained in the wine ingestion group for the variables of pain (p = 0.038), tender points (p < 0.001), and anxiety (p = 0.028). An improvement in the mean values was observed in favor of the experimental group for the variables of sadness, depression, and quality of life. The differences observed in the changes seen in the groups that were in favor of the wine ingestion group should not be attributed to the consumption of drugs but to the fact that the experimental group had a light intake of red wine.

Conclusions: The results of this pilot study suggest a potential relationship between alcohol intake through the light consumption of red wine as part of the patients' diet and the improvement of the main symptoms of fibromyalgia. Future studies are necessary to confirm these preliminary data; a bigger sample and a controlled diet should be considered, and the mechanisms through which improvements are achieved should be analyzed.

Keywords: anxiety; fibromyalgia; fibromyalgia impact questionnaire; pain; wine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
CONSORT flow chart.
Figure 2
Figure 2
Comparative analysis of pain when controlling the intake of analgesic medication.
Figure 3
Figure 3
Comparative analysis of tender/sensitive points when controlling the drug intake.
Figure 4
Figure 4
Comparative analysis of sadness when controlling the SSRI intake.
Figure 5
Figure 5
Comparative analysis of anxiety levels.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. International Statistical Classification of Diseases and Related Health Problems 10th Revision, Version for 2007. Chapter XIII. Disease of the Musculoskeletal System and Connective Tissue (M00-M99). Soft Tissue Disorder (M60-M79). Fibromyalgia (M79.7) [(accessed on 3 February 2021)]. Available online: http://apps.who.int/classifications/apps/icd/icd10online/
    1. Velasco M. Dolor musculo-esquelético: Fibromialgia y dolor miofascial. Rev. Med. Clin. Condes. 2019;30:414–427. doi: 10.1016/j.rmclc.2019.10.002. - DOI
    1. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P., et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Arthritis Rheum. 1990;33:150–172. doi: 10.1002/art.1780330203. - DOI - PubMed
    1. Goldenberg D.L., Burckhardt C., Crofford L. Management of Fibromyalgia Syndrome. JAMA. 2004;292:2388–2395. doi: 10.1001/jama.292.19.2388. - DOI - PubMed
    1. Cabo A., Cerdá G., Trillo J.L. Fibromyalgia: Prevalence, epidemiologic profiles and economic costs. Med. Clin. 2017;149:441–448. doi: 10.1016/j.medcli.2017.06.008. - DOI - PubMed